GTBP vs HALO (GT Biopharma Inc. vs Halozyme Therapeutics Inc.)
Showing Closing Date Range from Oct 5 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
Today's Session Official Close
The regular trading session has completed and official closing prices are verified as of 7:30 PM ET. All metrics below represent finalized session performance.
GTBP leads by +2.11% Alpha Spread Today
GTBP is trading at +3.41% while HALO is at +1.30% .
Started At
Official opening auction price
Closed At
Official exchange closing price
Gained / Lost Today
Net return against previous session close
Today's Trading Range Position
Where each asset is currently trading relative to its Day Low and Day High
Session Liquidity & Volume
Trading activity, share volume, and estimated dollar liquidity
Session Ledger Comparison
Direct side-by-side breakdown of today's key auction and price metrics
| Metric | GTBP | HALO | Head-to-Head Advantage |
|---|---|---|---|
| Today's Return | +3.41% | +1.30% | GTBP +2.11% |
| Net Dollar Move | +$0.21 | +$1.41 | HALO higher move |
| Open Price | $6.31 | $108.87 | Gap: 2.44% vs 0.52% |
| Day High | $6.43 | $111.25 | Session peaks |
| Day Low | $6.20 | $107.43 | Session troughs |
| Intraday Spread | $0.23 | $3.82 | High/Low spread |
| Share Volume | 22.3K | 1.77M | HALO more active |
| Est. Dollar Volume | $141.9K | $194.09M | HALO higher liquidity |
Explore GTBP vs HALO Over Extended Timeframes
Today's session isolates intraday momentum. Switch to normalized multi-day timeframes to analyze historical correlations, cumulative returns, and divergence charts.